SecurityUS00448Q2012 / Achillion Pharmaceuticals, Inc.
InstitutionUbs Ag
Latest Disclosed Ownership201,372 shares
Latest Disclosed Value $ 2,010,000
Ubs Ag ownership in US00448Q2012 / Achillion Pharmaceuticals, Inc.

On November 12, 2014 - Ubs Ag filed a 13F-HR form disclosing ownership of 201,372 shares of Achillion Pharmaceuticals, Inc. (US:US00448Q2012) valued at $2,010,000 USD as of September 30, 2014. The entity filed a previous 13F-HR on August 14, 2014 disclosing 74,137 shares of Achillion Pharmaceuticals, Inc.. This represents a change in shares of 171.62% during the quarter.

Ubs Ag has a history of taking positions in derivatives of the underlying security () in the form of stock options. The firm currently holds call options representing 145,100 of underlying shares valued at $1,448,000 USD and put options representing 161,100 of underlying shares valued at $1,608,000 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

US00448Q2012 / Achillion Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2014-11-12 2014-09-30 13F ACHILLION PHARMACEUTICALS IN COM 00448Q201 201,372 127,235 171.62 2,010 257.65 0.0015
2014-08-14 2014-06-30 13F ACHILLION PHARMACEUTICALS IN COM 00448Q201 74,137 15,965 27.44 562 194.24 0.0004
2014-05-16 2014-03-31 13F/A-1 ACHILLION PHARMACEUTICALS IN COM 00448Q201 58,172 25,567 78.41 191 76.85 0.0002
2014-05-15 2014-03-31 13F ACHILLION PHARMACEUTICALS IN COM 00448Q201 58,172 191
2014-05-21 2013-12-31 13F/A-1 ACHILLION PHARMACEUTICALS IN COM 00448Q201 32,605 27,637 556.30 108 620.00 0.0001
2014-02-14 2013-12-31 13F ACHILLION PHARMACEUTICALS IN COM 00448Q201 32,605 108
2013-11-13 2013-09-30 13F ACHILLION PHARMACEUTICALS IN COM 00448Q201 4,968 -1,282 -20.51 15 -70.59 0.0000
2013-08-14 2013-06-30 13F ACHILLION PHARMACEUTICALS IN COM 00448Q201 6,250 6,250 51 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-11-12 2014-09-30 13F ACHILLION PHARMACEUTICALS IN COM Call 145,100 72.94 1,448 128.03 n/a n/a n/a
2014-08-14 2014-06-30 13F ACHILLION PHARMACEUTICALS IN COM Call 83,900 1,647.92 635 3,868.75 n/a n/a n/a
2014-05-16 2014-03-31 13F/A ACHILLION PHARMACEUTICALS IN COM Call 4,800 -89.12 16 -89.04 n/a n/a n/a
2014-05-15 2014-03-31 13F ACHILLION PHARMACEUTICALS IN COM Call 4,800 16 n/a n/a n/a
2014-05-21 2013-12-31 13F/A ACHILLION PHARMACEUTICALS IN COM Call 44,100 31.64 146 44.55 n/a n/a n/a
2014-02-14 2013-12-31 13F ACHILLION PHARMACEUTICALS IN COM Call 44,100 146 n/a n/a n/a
2013-11-13 2013-09-30 13F ACHILLION PHARMACEUTICALS IN COM Call 33,500 238.38 101 24.69 n/a n/a n/a
2013-08-14 2013-06-30 13F ACHILLION PHARMACEUTICALS IN COM Call 9,900 81 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-11-12 2014-09-30 13F ACHILLION PHARMACEUTICALS IN COM Put 161,100 361.60 1,608 509.09 n/a n/a n/a
2014-08-14 2014-06-30 13F ACHILLION PHARMACEUTICALS IN COM Put 34,900 1,486.36 264 3,671.43 n/a n/a n/a
2014-05-16 2014-03-31 13F/A ACHILLION PHARMACEUTICALS IN COM Put 2,200 -96.89 7 -97.02 n/a n/a n/a
2014-05-15 2014-03-31 13F ACHILLION PHARMACEUTICALS IN COM Put 2,200 7 n/a n/a n/a
2014-05-21 2013-12-31 13F/A ACHILLION PHARMACEUTICALS IN COM Put 70,700 109.17 235 130.39 n/a n/a n/a
2014-02-14 2013-12-31 13F ACHILLION PHARMACEUTICALS IN COM Put 70,700 235 n/a n/a n/a
2013-11-13 2013-09-30 13F ACHILLION PHARMACEUTICALS IN COM Put 33,800 344.74 102 64.52 n/a n/a n/a
2013-08-14 2013-06-30 13F ACHILLION PHARMACEUTICALS IN COM Put 7,600 62 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.